top of page


Screenshot 2021-11-11 at 15.46.15.png

Psephos and SEHTA

South East Health Technologies Alliance (SEHTA) is a health technology network organisation, providing business support for the benefit of its members who represent health technology SMEs, health professionals, care providers and academia.

Founded in 2005, SEHTA is as an organisation meeting and understanding the needs of small healthcare businesses, as one of the largest networks of individuals from Academia, Business and Care/Clinicians (with over 1,400 members), with the purpose of improving the health and care of the citizens of the UK as well as increasing wealth.  

SEHTA do this by offering support on a one-to-one basis through its business support services and one-to-many through workshops, training and other events.

Psephos has been the preferred regulatory partner with SEHTA for several years providing workshops, webinars and articles covering a wide range of regulatory, quality and clinical topics and resulting in growing relationships within the UK medtech eco-system.


Psephos and ABHI

ABHI supports the HealthTech community to provide products and services that help people live healthier lives. As the voice of the industry, they show the value of health technology and overcome barriers to people benefitting from it now and in the future. Members include leading multinationals through to small and medium sized enterprises. They represent the HealthTech industry to key stakeholders, such as governments, healthcare systems and regulators.

Psephos are proud to partner with ABHI and are delighted to offer a free 30-minute consultation to ABHI members to answer their regulatory questions.

To take up this offer, please contact Jane Hargreaves at Please quote your ABHI membership number in any correspondence.

Screenshot 2021-10-15 at 16.37.33.png

Psephos and CVDHub

The Cardiovascular Devices Hub (CVDHub) is a novel cross-speciality team based in the UK that bridges the gap between the clinical, engineering and industrial worlds helping SMEs overcome the hurdles involved in taking new devices from laboratory bench to patient.


Psephos has partnered with CVDHub to provide regulatory support for SMEs including an initial, pro bono, consultation designed to answer immediate questions to assist with strategic product development, market access and compliance to relevant regulations.  For further information about CVDHub click here.


Psephos and MedTech SuperConnector

Led by Imperial College London, MedTech SuperConnector (MTSC) provides funding, training, advice and access to industry networks. The accelerator programme allows Early Career Researchers (ECRs) to connect with peers from other academic institutions and the networking opportunities they need to help fast-track the translation of their research discoveries.

In partnership with SEHTA, Psephos is proud to present at the MedTech SuperConnector masterclasses on regulatory, quality and clinical strategy for early stage companies. For more information, please visit MedTech SuperConnector

If you're interested in collaborating with us..

Get in touch!

Thanks for submitting your message!
bottom of page